Contagion&reg Editorial Staff

The results of a new study have revealed that carbapenem resistance conferred by plasmids can be transferred among unrelated bacteria in the health care setting.

Xingmin Sun, PhD, shares current progress on developing a vaccine for Clostridium difficile infection.

Xingmin Sun, PhD, discusses aspects that need to be considered before developing a vaccine for Clostridium difficile.

Chelsea Drennan, PharmD(c) explains why hospital length-of-stay might be shorter in patients who are on a fluoroquinolone versus a beta-lactam.

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The therapy, used to treat and prevent bloodstream infections and related complications in patients who have central venous catheters, has been found to be ineffective in pediatric cancer patients.

The FDA has approved Lannet Company’s Abbreviated New Drug Application for levofloxacin oral solution USP, 25 mg/mL.

Fulphila is the first biosimilar to Neulasta to decrease the chance of infection in patients with non-myeloid cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.

Douglas Krakower, MD, discusses which variables in electronic health records could be used to identify candidates for pre-exposure prophylaxis.

The results of a new study reveal that rates of viral suppression in women infected with HIV have improved since 2001; however, control of diabetes mellitus has remained poor, regardless of HIV status.

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

All endoscopic procedures held a greater risk of postprocedure infection than screening mammography; however, they were still lower risk than bronchoscopy and cystoscopy.

The 5-year partnership grant is to support the development of novel immunotherapy agents that target multidrug-resistant Gram-negative bacterial infections.

The results of 2 studies indicate that patients who are overweight or obese have better mortality outcomes than patients who are at a normal weight when it comes to fighting off infectious diseases.

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A new study finds that some patients with sepsis who are discharged after initial treatment, and then seen through outpatient follow-up still have positive outcomes.

Leah H. Rubin, PhD, MPH, MA, discusses the importance of finding ways to improve cognitive function in women who are living with HIV.

Douglas Krakower, MD, explains how electronic health records have expanded in use in order to identify people at risk for diseases who could benefit from preventive interventions.

Bruce A. Mueller, PharmD, explains the risk factors for augmented renal clearance.

Bruce A. Mueller, PharmD, shares some of the pharmacokinetic alterations that occur in patients who are in acute kidney failure in the intensive care unit.

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

Kenneth P. Klinker, PharmD, and Jason M. Pogue, PharmD, share some strategies to address beta-lactam dosing issues that they employ at their institutions.

Edward J. Septimus, MD, explains how smaller hospitals can overcome the challenges that come with having fewer resources to implement a robust antibiotic stewardship program.

The new LN34 test provided fewer false-positive results than the current gold-standard test, as well as fewer inconclusive results, and no false negative results.

The US Food and Drug Administration (FDA) has approved once-daily oral Truvada to reduce the risk of sexually acquired HIV-1 in at-risk adolescents, in combination with safe-sex practices.

A newly identified porcine virus has been found to be able to get into human cells in the laboratory setting.